Lilly Halts Development of Alzheimer’s Disease Drug

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

Aug. 17 (Bloomberg) -- Eli Lilly & Co. said it will stop development of one of two Alzheimer’s drugs the company has in final testing after studies showed the treatment didn’t work. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change